LONDON, Aug 3 (Reuters) - Britain said on Monday it had
partnered with Indian drugmaker Wockhardt to boost
COVID-19 vaccine manufacturing and hopes the firm's could start
work as soon as next month.
The agreement would see Wockhardt carry out the ‘fill and
finish’ stage of the manufacturing process, which involves
dispensing the manufactured vaccine substance into vials ready
for it to be distributed.
"Today we have secured additional capacity to manufacture
millions of doses of multiple COVID-19 candidates, guaranteeing
the supply of vaccines we need to protect people across the UK
rapidly and in large numbers," said British business minister
Alok Sharma in a statement.
(Reporting by Costas Pitas; editing by William James)
Glaxosmithkline (GSK)
Astrazeneca (AZN)
